NIH Launches New Covid-19 Test Assessment Tool
New web-based platform, developed with NIH funding, will aid in monitoring emerging SARS-CoV-2 variants and the performance of diagnostic tests.
Read MorePosted by Laurie Bonner | Mar 23, 2021 | Covid 19, Molecular Diagnostics |
New web-based platform, developed with NIH funding, will aid in monitoring emerging SARS-CoV-2 variants and the performance of diagnostic tests.
Read MorePosted by Melanie Hamilton-Basich | Mar 22, 2021 | Covid 19 |
The partnership will work toward CE marking of Aptamer Group’s AptaDx SARS-CoV-2 lateral flow rapid antigen test for professional use, to detect the SARS-CoV-2 spike protein antigen in anterior nasal swabs.
Read MorePosted by Laurie Bonner | Mar 22, 2021 | Covid 19 |
What “silver linings” has the pandemic response brought to you and your lab? What changes have occurred, for better or for worse, where you work?
Read MorePosted by Melanie Hamilton-Basich | Mar 19, 2021 | Covid 19 |
Scientific American takes an in-depth look at the United States’ mistakes—including sidelining experts and flawed testing—and successes in responding to the covid-19 crisis.
Read MorePosted by Melanie Hamilton-Basich | Mar 19, 2021 | Tuberculosis |
Oxford Immunotec is recognized as a global leader of proprietary test kits for latent tuberculosis. known for its T-SPOT.TB test.
Read More